Shared Decision-making in the U.S.: Evidence exists, but implementation science must now inform policy for real change to occur.

Implementation science Implementierungswissenschaft Partizipative Entscheidungsfindung Policy Politik Shared decision making United States Vereinigte Staaten von Amerika

Journal

Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen
ISSN: 2212-0289
Titre abrégé: Z Evid Fortbild Qual Gesundhwes
Pays: Netherlands
ID NLM: 101477604

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 15 04 2022
revised: 25 04 2022
accepted: 29 04 2022
pubmed: 23 5 2022
medline: 22 6 2022
entrez: 22 5 2022
Statut: ppublish

Résumé

Shared decision making (SDM) is defined as an approach in which clinicians and patients share the best available evidence when faced with the task of making decisions, and in which patients are supported to consider options to achieve informed preferences [1]. Over the past decade, SDM has been increasingly recognized as a component of value-based care in the US. There is greater acceptance overall that SDM is a key strategy for achieving patient-centered care, enhancing patient safety, and achieving the triple aim of better health, better care, and lower costs [2]. Essential elements of SDM include recognizing and acknowledging that a decision is required; knowing and understanding the best available evidence on risks and benefits; and incorporating the patient's values and preferences into the decision [3]. This paper provides an update of our previous review of SDM in the US published in 2017. We describe changes in healthcare policies to support SDM at the federal and state levels, the integration of SDM into clinical practice, and the role of implementation science to advance SDM. Finally, we discuss potential next steps to inform policies for SDM and facilitate uptake of SDM in clinical practice.

Identifiants

pubmed: 35599230
pii: S1865-9217(22)00082-4
doi: 10.1016/j.zefq.2022.04.031
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

144-149

Informations de copyright

Copyright © 2022. Published by Elsevier GmbH.

Auteurs

Yuan Lu (Y)

Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Connecticut, USA; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, USA.

Glyn Elwyn (G)

The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, USA.

Benjamin W Moulton (BW)

Informed Medical Decisions Foundation, Healthwise Research and Advocacy, Boston, USA.

Robert J Volk (RJ)

Department of Health Services Research, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, USA.

Dominick L Frosch (DL)

Palo Alto Medical Foundation Research Institute, Palo Alto, USA; Department of Medicine, University of California, Los Angeles, Los Angeles, USA.

Erica S Spatz (ES)

Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Connecticut, USA; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, USA. Electronic address: erica.spatz@yale.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH